Implantable Cardioverter-Defibrillator Therapy After Acute Myocardial Infarction. The Results Are Not Shocking

Journal of the American College of Cardiology

Volumn 54, Issue 22, 2009, Pages 2001-2005

  Goldberger, Jeffrey J ^a   Passman, Rod ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

implantable defibrillator; myocardial infarction; sudden death

Indexed keywords

ACUTE HEART INFARCTION; DEFIBRILLATOR; HEART ARREST; HEART LEFT VENTRICLE FAILURE; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE REMODELING; HIGH RISK PATIENT; KAPLAN MEIER METHOD; MORTALITY; PRIORITY JOURNAL; PROPHYLAXIS; REVIEW; SUDDEN DEATH;

DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; HUMANS; MYOCARDIAL INFARCTION; MYOCARDIUM; RISK ASSESSMENT; STROKE VOLUME; TACHYCARDIA, VENTRICULAR; TIME FACTORS; VENTRICULAR DYSFUNCTION, LEFT;

EID: 71849085003     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2009.08.018     Document Type: Review

References (30)

1. Myerburg R.J., Kessler K.M., and Castellanos A. Sudden cardiac death. Structure, function, and time-dependence of risk. Circulation 85 (1992) I2-I10
2. Solomon S.D., Zelenkofske S., McMurray J.J., et al. Sudden death in patients with myocardial infarction and left ventricular dysfunction, heart failure, or both. N Engl J Med 352 (2005) 2581-2588
3. Hohnloser S.H., Kuck K.H., Dorian P., et al. Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction. N Engl J Med 351 (2004) 2481-2488
4. Buxton A.E., Lee K.L., Fisher J.D., Josephson M.E., Prystowsky E.N., and Hafley G. A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators. N Engl J Med 341 (1999) 1882-1890
5. Moss A.J., Zareba W., Hall W.J., et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 346 (2002) 877-883
6. Moss A.J., Hall W.J., Cannom D.S., et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators. N Engl J Med 335 (1996) 1933-1940
7. Bardy G.H., Lee K.L., Mark D.B., et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 352 (2005) 225-237
8. Steinbeck G., Andresen D., Senges J., Hoffmann E., Seidl K., and Brachmann J. Immediate Risk-Stratification Improves Survival (IRIS): study protocol. Europace 6 (2004) 392-399
9. Wit A.L., Dillon S.M., Coromilas J., Saltman A.E., and Waldecker B. Anisotropic reentry in the epicardial border zone of myocardial infarcts. Ann NY Acad Sci 591 (1990) 86-108
10. Yousef Z.R., Redwood S.R., and Marber M.S. Postinfarction left ventricular remodeling: a pathophysiological and therapeutic review. Cardiovasc Drugs Ther 14 (2000) 243-252
11. Pu J., and Boyden P.A. Alterations of Na+ currents in myocytes from epicardial border zone of the infarcted heart. A possible ionic mechanism for reduced excitability and postrepolarization refractoriness. Circ Res 81 (1997) 110-119
12. Qin D., Zhang Z.H., Caref E.B., Boutjdir M., Jain P., and el-Sherif N. Cellular and ionic basis of arrhythmias in postinfarction remodeled ventricular myocardium. Circ Res 79 (1996) 461-473
13. Guth L. Regeneration in the mammalian peripheral nervous system. Physiol Rev 36 (1956) 441-478
14. Levi-Montalcini R. Growth control of nerve cells by a protein factor and its antiserum: discovery of this factor may provide new leads to understanding of some neurogenetic processes. Science 143 (1964) 105-110
15. Zhou S., Chen L.S., Miyauchi Y., et al. Mechanisms of cardiac nerve sprouting after myocardial infarction in dogs. Circ Res 95 (2004) 76-83
16. Verrier R.L., and Kwaku K.F. Frayed nerves in myocardial infarction: the importance of rewiring. Circ Res 95 (2004) 5-6
17. Minardo J.D., Tuli M.M., Mock B.H., et al. Scintigraphic and electrophysiological evidence of canine myocardial sympathetic denervation and reinnervation produced by myocardial infarction or phenol application. Circulation 78 (1988) 1008-1019
18. Kammerling J.J., Green F.J., Watanabe A.M., et al. Denervation supersensitivity of refractoriness in noninfarcted areas apical to transmural myocardial infarction. Circulation 76 (1987) 383-393
19. Gaudron P., Kugler I., Hu K., Bauer W., Eilles C., and Ertl G. Time course of cardiac structural, functional and electrical changes in asymptomatic patients after myocardial infarction: their inter-relation and prognostic impact. J Am Coll Cardiol 38 (2001) 33-40
20. Wilber D.J., Zareba W., Hall W.J., et al. Time dependence of mortality risk and defibrillator benefit after myocardial infarction. Circulation 109 (2004) 1082-1084
21. Pitt B., Remme W., Zannad F., et al. Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 348 (2003) 1309-1321
22. Pitt B. Sudden death in patients with myocardial infarction. N Engl J Med 353 (2005) 1294-1297
23. Raviele A., Bongiorni M.G., Brignole M., et al. Early EPS/ICD strategy in survivors of acute myocardial infarction with severe left ventricular dysfunction on optimal beta-blocker treatment. The BEta-blocker STrategy plus ICD trial. Europace 7 (2005) 327-337
24. Exner D.V., Kavanagh K.M., Slawnych M.P., et al. Noninvasive risk assessment early after a myocardial infarction the REFINE study. J Am Coll Cardiol 50 (2007) 2275-2284
25. Daubert J.P., Zareba W., Cannom D.S., et al. Inappropriate implantable cardioverter-defibrillator shocks in MADIT II: frequency, mechanisms, predictors, and survival impact. J Am Coll Cardiol 51 (2008) 1357-1365
26. Moss A.J., Greenberg H., Case R.B., et al. Long-term clinical course of patients after termination of ventricular tachyarrhythmia by an implanted defibrillator. Circulation 110 (2004) 3760-3765
27. Poole J.E., Johnson G.W., Hellkamp A.S., et al. Prognostic importance of defibrillator shocks in patients with heart failure. N Engl J Med 359 (2008) 1009-1017
28. Smith J.R., Kadish A.H., Inbar S., Ye D., and Goldberger J.J. Local electrogram changes in response to a high-voltage intracardiac shock in humans. J Cardiovasc Electrophysiol 7 (1996) 387-397
29. Berg M.D., Banville I.L., Chapman F.W., et al. Attenuating the defibrillation dosage decreases postresuscitation myocardial dysfunction in a swine model of pediatric ventricular fibrillation. Pediatr Crit Care Med 9 (2008) 429-434
30. Hasdemir C., Shah N., Rao A.P., et al. Analysis of troponin I levels after spontaneous implantable cardioverter defibrillator shocks. J Cardiovasc Electrophysiol 13 (2002) 144-150